Catheter Precision Inc (VTAK) Stock Analysis
Verdict: AVOID
Severe liquidity distress with $88k cash against -$8.3M operating cash burn signals imminent dilution or insolvency.
Investment score: 10/100
Analysis as of
Is Catheter Precision Inc stock worth reviewing? AI model thesis
Catheter Precision suffers from near-total cash exhaustion ($88k remaining) and extreme share dilution (shares surged from 3.26M to 1.08B in 2025). The AI model rates this stock as a clear AVOID due to high insolvency risk.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 0/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 25/100 (weight 10%)
- Risk-Adjusted Return: 5/100 (weight 15%)
Catheter Precision Inc opportunities and risks
What speaks for VTAK
- VIVO System adoption acceleration
What speaks against VTAK
- Imminent cash exhaustion and default risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| VTAK | n/a | 0.3x | n/a | 47.7% | -693.9% | -1773.6% |
| AEMD | n/a | 0.0x | 0.5x | 0.0% | 0.0% | -157395.5% |
| ESMC | 1.7x | 0.1x | 3712.5x | 41.5% | 16.2% | 21020.0% |
| VBIO | n/a | 0.3x | n/a | 38.8% | -727.8% | -1025.1% |
| LGMK | n/a | 0.1x | 0.5x | 56.9% | -50.2% | -448.7% |
| MCIC | n/a | 0.0x | n/a | 0.0% | 0.0% | -6.6% |
| Peer median | n/a | 0.1x | 0.5x | 38.8% | 0.0% | -448.7% |
Frequently asked questions about Catheter Precision Inc (VTAK)
Is VTAK stock a good investment?
The cached TradeMates AI model rates Catheter Precision Inc as AVOID with an investment score of 10/100. Catheter Precision suffers from near-total cash exhaustion ($88k remaining) and extreme share dilution (shares surged from 3.26M to 1.08B in 2025). The AI model rates this stock as a clear AVOID due to high insolvency risk. This is algorithmic model output, not personal investment advice.
Is VTAK stock a buy?
The TradeMates model verdict for VTAK is AVOID with an investment score of 10/100. Treat this as a model signal to review, not a personal buy recommendation.